Chimerix (CMRX) Misses Q3 EPS by 4c

Chimerix (NASDAQ: CMRX) reported Q3 EPS of ($0.27), $0.04 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $32.55 thousand versus the consensus estimate of $89.17 thousand.

For earnings history and earnings-related data on Chimerix (CMRX) click here.

You May Also Be Interested In

• AI and earnings keep driving markets as focus shifts to Trump-Xi summit
• On Holding sets 2029 financial targets, authorizes $1B share buyback
• AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c